Therefore, we hypothesize that Oct4 can regulate cervical cancer development by binding IL-17A to modulate p38 pathway, and that Oct4 transcriptionally activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis. This evidence concerns the gene IL17A and cervical carcinoma.